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Abstract 
Human Adipose-derived Stem Cells (hASCs) are a promising cell type for bone tissue 
engineering, given their potential to differentiate into osteoblast-like cells. Interactions 
among biochemical and mechanical signals result in bone formation and repair. In this 
process stem cells have a crucial role. Extracorporeal Shock Waves (ESW) are acoustic 
waves capable of enhancing bone regeneration suggesting that ESW may induce some 
signals for mesenchymal progenitor maturation. The aim of the present work is to 
investigate the effects of ESW treatment on the differentiation of hASCs into 
osteoblast-like cells and to better clarify the mechanisms involved. hASCs were treated 
with ESW and osteogenic medium; the effects in terms of gene expression, alkaline 
phosphatase (ALP) activity and calcium deposition were then evaluated. Moreover, to 
investigate the mechanisms of ESW action, reactive oxygen species (ROS) production, 
extracellular-signal-regulated kinases (ERK) and small 'mothers against' 
decapentaplegic (Smad) phosphorylation, and bone morphogenetic protein 2 (BMP2) 
expression were assessed. ESW treatment increased Runt related transcription factor 2 
(Runx2), ALP and BMP2 expression, as well as ALP activity and calcium deposits with 
respect to untreated cells. Moreover ESW induced ROS formation, and both ERK and 
Smad phosphorylation. Our study shows the effects of ESW on osteogenic 
differentiation in an in vitro model using human adipose-derived stem cells and defines 
the mechanisms involved in this process. Our observations suggest that the combination 
of autologous hASCs and ESW treatment may improve bone tissue repair in tissue 
engineering procedures. 
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1. INTRODUCTION 
Extensive bone loss due to trauma, inflammation and neoplasia are still a major clinical 
issue. The goal of bone tissue engineering is to enhance the regenerative ability of 
damaged bone as well as to identify novel cell-based therapies when repair processes 
are deficient. Human mesenchymal stem cells (MSCs) are a promising candidate cell 
type for musculoskeletal regenerative tissue engineering due to their capacity for self-
renewal and multipotent differentiation. In fact, under specific conditions, MSCs are 
able to differentiate into bone, cartilage, and tendon (Pountos and Giannoudis, 2005). 
To date the majority of cell-based tissue regenerative protocols have involved the use of 
bone marrow MSCs; however, only a limited supply of cells can be obtained from bone 
marrow harvesting. In 2001, Zuk et al. first demonstrated that multilineage 
mesenchymal progenitor cells, similar to those obtained from bone marrow, are present 
in adipose tissue (Zuk et al., 2001). Human adipose tissue represents a good candidate 
source of adult stem cells (human Adipose-derived Stem Cells, hASCs) because it is 
available in large quantities and can be collected by liposuction, not such an invasive 
procedure. Bone formation and repair are the result of interaction among biochemical 
and mechanical signals. Both processes involve the expression of multiple soluble and 
intracellular factors in a coordinated cascade of events. The musculoskeletal system 
responds to the loading environment and mechanical loading influences biological 
tissues (Maul et al., 2011; Soucacos et al., 2008). Extracorporeal Shock Waves (ESW) 
are transient short-term acoustic pulses with high peak pressure and a very short rise 
time to peak pressure on the order of magnitude of nanoseconds (one billionth of a 
second) and short pulse duration. ESW technology has been used in clinical practice 
since the 1980s, when lithotripters were first employed to break up kidney stones 
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(Sturtevant, 1996). More recently, shockwave therapy has emerged as a leading choice 
in the treatment of several orthopedic diseases (Wang, 2012a); in bone disorders, ESW 
treatment is being used successfully for non-union and delayed union of long bone 
fractures (Elster et al., 2010; Xu et al., 2009; Wang et al., 2001; Rompe et al., 2001) 
and for avascular necrosis of the femoral head (Alves et al., 2009; Chen et al., 2009; 
Wang et al., 2012b). Experimental studies in animals have shown that ESW have 
osteogenic potential on damaged bone and promote bone union of segmental defect in 
rats (Wang et al., 2003; Chen et al., 2004a; Chen et al., 2004b);  ESW induce new bone 
formation in rabbits (Tischer et al., 2008); they have anabolic effects in normal (van der 
Jagt et al., 2011) and in osteoporotic rat bone (van der Jagt et al., 2013); at 
osteotendinous junction with delayed healing they induce osteogenesis (Qin et al., 
2010), indicating that the bone microenvironment is responsive to physical ESW 
stimulation. Interestingly, it has been reported that ESW stimulate both the recruitment 
and the osteogenic differentiation of stem cells (Chen et al., 2004b), and increase 
proliferation and differentiation of MG-63 human osteoblast-like cells by modifying ion 
channel activity without interfering with normal cell activity (Muzio et al., 2010).  
Although it has already been demonstrated that ESW drive progenitor cell 
differentiation towards osteogenic cell lineages through the production of TGF and 
VEGF (Wang et al., 2002a, Chen et al., 2004b) and oxygen radicals (Wang et al.,  
2002b), the molecular mechanisms by which ESW exert their action are far from being 
fully understood. 
The aim of the present study was to investigate the effects of ESW treatment on the 
differentiation of human adipose derived stem cells into osteoblast-like cells and to 
further explore the possible mechanisms involved in this process. 
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2. MATERIALS AND METHODS  
2.1. hASC isolation, characterization and osteogenic differentiation. 
hASCs were isolated from the subcutaneous-adipose tissue of 5 healthy female donors 
(range 30–50 yrs, BMI < 30 without any pathological obesity), undergoing elective 
liposuction, after written consent and Institutional-Review Board authorization. Primary 
cultures were established as follows: after digestion of raw lipoaspirates (50–100 ml) 
with 0.075% type I collagenase for 30 minutes, hASCs were separated by centrifugation 
(2100×g for 10 min), filtered and plated in basal medium (D-MEM/F12 plus 10% FBS). 
hASCs at passage 4 were investigated by flow cytometry analysis for the expression of 
several antigens using the following phycoerythrin (PE) or fluorescein isothiocyanate 
(FITC)-conjugated antibodies: mouse anti-human CD13, CD14 and CD34 (BD 
Biosciences, Fraklin Lakes, NJ, USA); mouse anti-human CD45, CD90, CD105, and 
CD44 (Immunotech, Marseille, France). Ten thousand events were acquired for each 
surface marker on flow cytometer (EPICS XL, Coulter Corp., Hialeah, FL).  
To induce osteo-differentiation, hASCs were cultured in osteogenic medium consisting 
of basal medium supplemented with 10 mM glycerol-2-phosphate, 10 nM 
dexamethasone, 150 μM ascorbic acid-2-phosphate, and 10 nM cholecalciferol (de 
Girolamo et al., 2007). hASCs cultured in basal medium were used as controls. 
2.2. ESW treatment 
The shock wave generator utilized for the in vitro experiments is a piezoelectric device 
(Piezoson 100, Richard Wolf, Knittlingen, Germany) especially designed for clinical 
use in orthopedics and traumatology. The experimental set-up has been previously 
reported (Frairia et al., 2003).  Briefly, aliquots of 1 ml of cell suspension adjusted to 1 
x 10
6
 cell/ml were placed in 20 mm polypropylene tubes (Nunc, Wiesbaden, Germany) 
 8 
 
which were then completely filled with culture medium. Subsequently, cells were gently 
pelleted by centrifugation at 250 x g in order to minimize motion during shock wave 
treatment. Each cell-containing tube was placed in vertical alignment with the focal area 
and was adjusted so that the central point of the focal area corresponded to the centre of 
the tube bottom. The shock wave unit was kept in contact with the cell containing tube 
by means of a water-filled cushion. Common ultrasound gel was used as a contact 
medium between cushion and tube. Cells were treated as follows: 1) control cells 
receiving no ESW treatment and maintained in D-MEM/F12 plus FBS 10% (DMEM); 
2) ESW-treated cells (EFD =0.32 mJ/mm
2
; 1000 shots, peak positive pressure 90 MPa) 
receiving a number of 1000 shots (frequency = 4 shocks per second) and maintained in 
D-MEM/F12 plus FBS 10% (DMEM ESW); 3) cells receiving no ESW treatment and 
maintained in osteogenic medium (OST); 4) ESW-treated cells (EFD =0.32 mJ/mm
2
; 
1000 shots) maintained in osteogenic medium (OST ESW). 
2.3. Cell viability 
After treatment, cells were seeded at 3 x 10
3
 cells/well in 96-well plates (Corning, New 
York, NY, USA). At 3, 6 and 10 days, cell viability was assessed using the Cell 
Proliferation Reagent WST-1 (Roche Applied Science, Penzberg, Germany), following 
the manufacturer’s instructions. This is a colorimetric assay for the quantification of cell 
viability and proliferation, based on cleavage of the tetrazolium salt WST-1 by 
mitochondrial dehydrogenases in viable cells. Briefly, 10 l of WST-1 were added to 
each well. After a 1 hour incubation, absorbance at 450 nm was measured using a plate 
reader (Model 680 Microplate Reader, Bio-Rad, Hercules, CA, USA). Four replicate 
wells were used to determine each data point. 
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2.4. Gene expression 
At defined times after treatment, total RNA was extracted using TRIzol
 
Reagent 
(Invitrogen Ltd, Paisley, UK). DNase I was added to remove remaining genomic DNA. 
1 g of total RNA was reverse-transcribed with iScript cDNA Synthesis Kit (Bio-Rad 
Laboratories Inc., Hercules, CA, USA), following manufacturer’s protocol. Primers 
(Table 1) were designed using Beacon Designer 5.0 software according to parameters 
outlined in the Bio-Rad iCycler Manual. Specificity of primers was confirmed by 
BLAST analysis. Real-time PCR was performed using a BioRad iQ iCycler Detection 
System (Bio-Rad Laboratories Inc., Hercules, CA, USA) with SYBR green fluorophore. 
Reactions were performed in a total volume of 25 l containing 12.5 l IQ SYBR Green 
Supermix (Bio-Rad Laboratories Inc., Hercules, CA, USA), 1 l of each primer at 10 
M concentration, and 5 l of the previously reverse-transcribed cDNA template. The 
protocol used is as follows: denaturation (95°C for 5 min), amplification repeated 40 
times (95°C for 15 sec, 60°C for 30 sec). A melting curve analysis was performed 
following every run to ensure a single amplified product for every reaction. All 
reactions were carried out at least in triplicate for each sample. Results were normalized 
using the geometric mean for three different housekeeping genes (-actin, 2-
microglobulin and L13A) and expressed as relative expression fold versus untreated 
controls. 
2.5. Alkaline Phosphatase activity 
Alkaline Phosphatase (ALP) activity, as described elsewhere (Maroni et al., 2012), was 
measured in cell lysates (0.1% Triton X-100), using as substrate 1 mM p-
nitrophenylphosphate in alkaline buffer (100 mM diethanolamine and 0.5 mM MgCl2, 
 10 
 
pH 10.5), and evaluating the absorbance at 405 nm on a multiplate reader (Model 680 
Microplate Reader, Bio-Rad).  
 
2.6. Alizarin Red Staining 
Calcium deposition was measured by staining with 40 mM Alizarin Red-S (ARS, pH 
4.1). After fixation in ethanol and washing with Tris-buffered saline, cells were stained 
with ARS for 15 minutes, washed with Tris-buffered saline, and observed under light 
microscope. Thereafter, calcium content was quantitatively analysed as previously 
described (Maroni et al., 2012). Briefly, ARS was destained with 10% cetylpyridinium 
chloride (Sigma–Aldrich, Saint Louis, MO, USA) in 10 mM sodium phosphate buffer 
for 15 min at room temperature. Calcium content was determined by the absorbance 
measurement on a multiplate reader at 550 nm (Model 680 Microplate Reader, Bio-
Rad). 
2.7. Immunoblotting 
At different times after treatments, cells were scraped from the flask in the presence of 1 
ml lysis buffer (50 mM Tris–HCl pH 7.5, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 
0.5% sodium deoxycholate, 1% Nonidet P-40, 0.1% SDS, 10 mg/ml PMSF, 30 ml/ml 
aprotinin and 100 mM sodium orthovanadate). Cell lysates were incubated in ice for 
30–60 min. At completion, tubes were centrifuged at 4 °C for 20 min at 15,000 × g. 
Clear supernatants were stored at −80 °C until use. For the assay, 4 μg of anti-total ERK 
1/2  antibody (Upstate Biotechnology, Lake Placid NY, USA) were incubated with 100 
μl of a slurry of 50% protein A agarose beads (Sigma–Aldrich, Saint Louis, MO, USA) 
for 30 min at 4 °C. Cell extracts containing 1 mg total protein per sample were 
precipitated with the beads for 2 h at 4 °C. Precipitated immunocomplexes were 
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separated on SDS-PAGE, transferred to PVDF and probed with monoclonal antibodies 
anti-phospho (Upstate Biotechnology, Lake Placid, NY, USA) and anti-total ERK 1/2 
antibodies. Chemioluminescence detection was performed following ECL 
manufacturer's instructions. Bands were photographed and their intensity analysed with 
1D Kodak Digital Science software. 
2.8. Immunofluorescence microscopy  
After treatment, cells (3 x 10
5
) were seeded in 6 cm dishes. After 6 hours, cells were 
first put in acetone/methanol (1:1) at -20 °C for 20 minutes, washed with PBS 
containing 0.5% Triton X-100, 0.05% NaN3 and incubated with anti-phospho-Smad 
1/5/8 (mouse, Santa Cruz Biotechnology Inc, Santa Cruz, CA, USA), or anti-total-Smad 
1/5/8 (mouse, Santa Cruz Biotechnology Inc, Santa Cruz, CA, USA) antibodies at 4°C 
overnight. Then cells were washed with PBS containing 0.5% Triton and 0.05% NaN3 
for 10 minutes for three times followed by detection with anti-mouse cy3 conjugated 
secondary antibodies, (GE Healthcare Europe, GmbH, Milan, Italy) in PBS plus 0.5% 
Triton and 0.05% NaN3 for 2 hours. Nuclear staining was obtained by treating cells with 
Hoechst 33258 (500ng/ml in DMSO) in PBS. Cells were washed twice with distilled 
water and mounted with 50% glycerol-PBS media.  
2.9. Intracellular ROS determination 
Reactive oxygen species (ROS) were measured using 2’,7’-dichloro-fluorescein 
(DCFH) diacetate as a probe (Canaparo et al., 2006). Adherent cells were incubated 
with 5 M DCFH for 30 minutes at 37°C in the dark. Intracellular ROS levels were 
measured using a flow cytometer (EPICS XL, Coulter Corp., Hialeah, FL).  
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2.10. Statistical Analysis 
Data are expressed throughout the text as means  SD. The means were calculated from 
at least three different experiments, each from different donors. Comparison between 
groups was performed with analysis of variance (two-way ANOVA) and the threshold 
of significance was calculated with the Bonferroni test. Statistical significance was set 
at p<0.05. 
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3. RESULTS 
3.1. hASC characterization and ESW effect on cell viability 
More than 95% of hASCs expressed CD13, CD44 and CD105, whereas a very low 
expression of CD14 (1-4%) and no expression of CD34 and CD45 was detected. 
Moreover, a positivity of at least 95% for the same markers was also maintained in 
subsequent steps (data not shown). 
The energy level and number of shots used for ESW treatment (EFD =0.32 mJ/mm
2
; 
peak positive pressure 90 MPa, 1000 shots) permitted a viability > 80% and no 
significant difference in terms of cell growth was observed between ESW treated and 
untreated cells, up to 10 days after treatment (supplementary figure 1). 
3.2. ESW affect early osteogenic gene expression and alkaline phosphatase activity 
As reported in figure 1, 72 h after treatment, ESW and osteogenic medium determined, 
even if used alone, a significant increase of Runx2 (panel A, DMEM ESW vs DMEM: 
1.3 times, p<0.05; OST vs DMEM: 1.9 times, p<0.01) and ALP (panel B, DMEM ESW 
vs DMEM: 2.2 times, p<0.01; OST vs DMEM: 3.8 times, p<0.001) gene expression, 
though the greatest effect was achieved using the osteogenic medium/ESW combined 
treatment (for Runx2, panel A: OST ESW vs DMEM: 3.5 times, p<0.001; OST ESW vs 
OST: 1.9 times, p<0.01; for ALP, panel B: OST ESW vs DMEM: 6.6 times, p<0.001; 
OST ESW vs OST: 1.6 times, p<0.01). The enzymatic ALP activity confirmed the gene 
expression data (figure 1, panel C); once more, the combined treatment had the greatest 
effect (DMEM ESW vs DMEM: 1.4 times, p<0.05; OST vs DMEM: 1.8 times, p<0.01; 
OST ESW vs OST: 1.4 times, p<0.01; OST ESW vs DMEM: 2.6 times, p<0.001). 
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3.3. ESW affect mineralization 
To further confirm the differentiation into osteoblasts induced by ESW and osteogenic 
medium, the presence of calcium deposits produced by differentiating cells was 
determined (figure 2, panels A and B). 28 days after treatment, calcium deposits, 
revealed by Alizarin Red staining, were observed both in cells treated with only ESW 
(figure 2, panel A-II) and with osteogenic medium alone (figure 2, panel A-III). 
However, again, the combined treatment (OST ESW) had the greatest effect (figure 2, 
panel A-IV), confirming the results of gene expression and ALP activity. Quantification 
of ARS (figure 2, panel B) confirmed the significant increase in calcium deposits 
already in the cells treated with ESW alone (DMEM ESW vs DMEM, p<0.01). 
Osteogenic medium determined a further increase in calcium deposits (OST vs DMEM, 
p<0.001), but it was the combined treatment with osteogenic medium and ESW which 
had the greatest effect (OST ESW vs DMEM, p<0.001; OST ESW vs OST, p<0.05).  
3.4. ESW determine ROS production 
Since it has been reported that ESW treatment, through reactive oxygen species 
production, induces osteogenic differentiation of bone marrow-derived mesenchymal 
stem cells (Wang et al., 2002b), we determined ROS production after ESW treatment in 
hASCs. As reported in figure 3, panel A, 1 minute after ESW treatment, a significant 
increase in ROS production was already observed both in control and osteogenic 
medium, with respect to no ESW treatment (DMEM ESW vs DMEM: 11.5 times, 
p<0.001; OST ESW vs OST: 11.6 times, p <0.001). The increase was maintained until 5 
min after treatment (DMEM ESW vs DMEM: 9.4 times, p <0.001; OST ESW vs OST: 
12.3 times, p <0.001) but was not evaluable at successive times (determined up to 1 
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hour), where an increase was also observed in the samples not treated with ESW with 
respect to untreated cells at 1 minute (data not shown). 
3.5. ESW activate ERK1/2 to induce osteogenic differentiation  
Since ROS are able to determine ERK phosphorylation (Wang et al., 2002b), we 
evaluated the effect of ESW on ERK1/2 phosphorylation level. As reported in figure 3, 
panel B, an increase in ERK 1/2 phosphorylation was already observed 15 minutes after 
ESW treatment in both basal conditions (DMEM ESW vs DMEM, p <0.05) and in 
osteogenic medium (OST ESW vs DMEM, p <0.05). The increase in ERK 
phosphorylation levels induced by ESW returned to basal condition levels after 60 min. 
The rapid and transient activation of this signaling cascade pathway suggests a response 
directly elicited by the mechanical stimulus. A similar effect has already been reported 
as result of mechanical strength in myocites and cardiomyocites (Rauch et al., 2008; 
Komuro et al., 1996). 
3.6. ESW determine Smad phosphorylation 
BMP2 signaling regulates osteogenic differentiation, acting through the Smad pathway 
(Phimphilai et al., 2006; Liu et al., 2011). In our in vitro model ESW determined the 
induction in BMP2 expression (DMEM ESW vs DMEM: 14 times, p<0.001; OST ESW 
vs OST: 20 times, p<0.001) (figure 4, panel A). Moreover, ESW treatment determined 
the nuclear localization of Smad (arrows, figure 4, panel B) which is the phosphorylated 
active form (arrows, figure 4, panel C). 
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4. DISCUSSION 
In the present paper we have shown that extracorporeal shockwave treatment can 
promote and improve osteogenic medium-induced differentiation into osteoblast-like 
cells of adipose-derived stem cells. The evaluation of mesenchymal expression markers 
showed that the hASCs we isolated met the criteria of mesenchymal stem cells. 
Moreover, the fact that the same markers were also positive in subsequent steps 
guaranteed that the cells preserved their initial characteristics as long as they were used. 
The present paper confirmed the effect of a well characterized medium (de Girolamo et 
al., 2007; Maroni et al., 2012) on osteoblast gene expression, ALP activity and calcium 
deposits. The novelty of the present work is the ability of ESW to promote the process 
of hASC differentiation even when used alone, and to boost the process of 
differentiation induced by the osteogenic medium. In fact, ESW treatment without any 
biochemical supplement determined a significant increase in Runx2, ALP and BMP2 
expression as well as an increase in ALP activity and calcium deposits. So far, the 
biophysical induction of hASC differentiation has been reported by several authors but 
only in the presence of an induction medium, suggesting that mechanical loading might 
only boost differentiation. Nevertheless, our data are in line with a recent study 
demonstrating that mechanical stress alone (mediated by a microstructured nitinol 
actuator) can induce osteogenic differentiation (Strauß et al., 2012). Some authors have 
reported that in in vivo animal models ESW activated cell proliferation and bone 
regeneration of segmental defects (Wang et al., 2003) and that the ESW-promoted 
healing was achieved by stimulation of mesenchymal stem cell recruitment and 
differentiation into bone-forming cells (Chen et al., 2004b). This is the first report to 
show the effects of ESW treatment on osteogenic differentiation in an in vitro model 
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using human adipose-derived stem cells and defining the mechanisms involved in the 
process of differentiation. Recently it has been reported that ESW lead to osteogenic 
differentiation of bone marrow-derived stem cells via P2X7 (purinergic receptor P2X 
ligand-gated ion channel 7) signaling (Sun et al., 2013); our data are in good agreement 
with the effects of ESW observed and add new insights into the mechanisms involved. 
Moreover, in a recent paper on equine ASCs (Raabe et al., 2013), the authors reported a 
relevant effect of ESW on ASC proliferation but no significant influence on 
differentiation; the use of cells of different origin and ESW schedules may at least 
partially explain the differences observed.  
To get insight into the mechanisms of the ESW effect, we investigated ROS production 
in hASCs. We observed ROS production after only 1 minute from the treatment, 
regardless of the presence of osteogenic medium. ROS production is involved not only 
in cellular proliferation but also in differentiation (Kanda et al., 2011; Sauer et al., 
2000). Induction of ROS by ESW treatment is in agreement with a previous report 
demonstrating that O2
-
 mediated the ESW-induced ERK activation and osteogenic 
differentiation of bone marrow mesenchymal stem cells (Wang et al., 2002b). 
Moreover, ROS production has been found to increase during the differentiation of 
human mesenchymal stem cells into adipocytes (Tormos et al., 2011). Franceschi et al. 
(2003) reported that the transcription factor Runx2, necessary for osteoblast 
differentiation and bone formation, is a target of mechanotransduction and it is 
responsive to multiple pathways, mostly MAPK and BMP2/Smad signaling. Our data 
confirmed that ESW treatment determined ERK phosphorylation as well as BMP2 
expression and Smad phosphorylation. The ERK pathway is reported as a classical 
signaling pathway that regulates mechanical force-induced up-regulation of osteogenic 
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differentiation of MSCs (Zhang et al., 2012; Kim et al., 2010) and its phosphorylation is 
involved in the activation of Runx2 (Franceschi et al., 2007). BMPs are important 
osteogenic mediators in the regulation of new bone formation (Gazzero et al., 2006). 
Our data are in line with previous reports demonstrating that ESW treatment increased 
the expression of BMP2 in experimental models of femur fractures (Wang et al., 2008) 
and necrotic femoral heads (Ma et al., 2008). Moreover, an increase in serum levels of 
BMP2 in patients treated with ESW for non-union fractures has been reported (Wang et 
al., 2009). BMP2/Smad signaling is believed to control Runx2 directly (Phimphilai et 
al., 2006; Liu et al., 2011); therefore, this pathway can be regarded as a possible 
mechanism explaining the effect of ESW treatment on Runx2 gene expression that we 
observed.  
Even though we are still far from elucidating all the mechanisms accounting for the 
effects of ESW in hASCs differentiation into osteoblast-like cells, the results reported in 
the present paper, in addition to previous data from the literature, define important 
signaling pathways involved in the mechanotransduction of ESW, as depicted in figure 
5. ESW, in particular, determine ROS production and induce ERK phosphorylation. On 
the one hand, this leads to BMP2 expression and Smad phosphorylation, which, as 
reported elsewhere (Phimphilai M et al., 2006; Liu et al., 2011), may regulate Runx2 
expression. On the other hand, it has been reported that ERK phosphorylates Runx2 
(Kanno T et al., 2007; Liu et al., 2011), inducing its transcriptional activity. Hence, both 
the induced expression of Runx2 and its augmented transcriptional activity explain, at 
least partially, the effect of ESW treatment on osteogenic differentiation of hASCs and 
suggest probable mechanisms by which shock waves promote bone healing. Our data 
suggest a time-dependent cascade of events that starts with ROS production elicited by 
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ESW and finally comes to a modulation of ALP protein function in terms of 
phosphatase activity and calcium deposits. 
In conclusion, this study represents an important step towards the combination of 
hASCs and ESW for tissue engineering procedures in the treatment of bone tissue 
damage. By using stem cells from adipose tissue the ethical problems related to the use 
of embryonic stem cells will be overcome. However, this is an in vitro study and the 
optimal energy intensity and number of shots are likely to vary in clinical applications, 
due to the different responses to ESW treatment elicited by different tissues. Additional 
in vivo work will be required to determine the real therapeutic potential of ESW and the 
set-up of clinical trials will definitively assess the use of ESW as an additional tool for 
improving the outcome of regenerative treatment.  
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Table 1 Primers for real-time PCR 
 
 
 
Runx2 
Sense: 5’- CGG AGT GGA CGA GGC AAG AG-3’ 
Antisense: 5’- AGG CGG TCA GAG AAC AAA CTA GG -3’ 
ALP
Sense: 5’- ATG AGG CGG TGG AGA TGG AC -3’ 
Antisense: 5’- CAT ACA GGA TGG CAG TGA AGG G -3’ 
BMP2 
Sense: 5’- CGG GAG AAG GAG GAG GCA AAG -3’ 
Antisense: 5’- GAA GCA GCA ACG CTA GAA GAC AG -3’ 
-ACT 
Sense: 5’- GCG AGA AGA TGA CCC AGA TC- 3’ 
Antisense: 5’- GGA TAG CAC AGC CTG GAT AG-3’ 
2-microglobulin 
Sense: 5’-AGA TGA GTA TGC CTG CCG TGT G-3’ 
Antisense: 5’-TCA ACC CTC CAT GAT GCT GCT TAC-3’ 
L1 
Sense: 5’-GCA AGC GGA TGA ACA CCA ACC-3’ 
Antisense: 5’-TTG AGG GCA GCA GGA ACC AC-3’ 
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Figure Legends 
Figure 1. Effects of ESW and osteogenic medium on Runx2 (A) and ALP (B) gene 
expression. mRNA expression was evaluated by RT-PCR after 72 hours from 
treatments. Results are normalized for three different housekeeping genes (β-actin, β2-
microglobulin and L13A) and expressed as relative expression fold vs lower level of 
expression. Effects of osteogenic medium and ESW on ALP activity (C): Enzymatic 
activity at day 6 was calculated as units normalized for total protein content (U/μg 
protein) and expressed as ratio vs DMEM. Level of significance vs DMEM: *, p<0.05; 
**, p<0.01; ***, p<0.001; level of significance vs no ESW: °, p<0.05; °°, p<0.01.  
Figure 2. Effect of ESW and osteogenic medium on calcium deposition. (A): 
Calcium deposits at 28 days (arrows) as revealed by Alizarin Red Staining. 
Magnification 400x. I: DMEM; II: DMEM ESW; III: OST; IV: OST ESW. (B): 
Staining quantification was normalized for DNA content and expressed as ratio vs 
DMEM. Level of significance vs DMEM: **, p<0.01; ***, p<0.001; level of 
significance vs no ESW: °, p<0.05; °°, p<0.01. 
Figure 3. Effects of ESW on ROS formation (A): Intracellular ROS levels measured 
using a flow cytometer. Level of significance vs no ESW: ***, p<0.001. Effects of 
ESW on ERK1/2 phosphorylation (B): ERK phosphorylation in either DMEM or 
osteogenic medium, after EWS treatment (upper panel). Total ERK 1/2 was evaluated in 
order to check the amount of loaded protein (lower panel). Histograms: semiquantitative 
analysis of Western blot results after 15’ and 60’. Level of significance vs no ESW: *, 
p<0.05. 
Figure 4. Effects of ESW and osteogenic medium on BPM2 expression (A): mRNA 
expression was evaluated with RT-PCR. Results are normalized for three different 
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housekeeping genes (β-actin, β2-microglobulin and L13A) and expressed as relative 
expression fold vs lower level of expression. Level of significance vs DMEM: *** 
p<0.001; level of significance vs no ESW: °°° p<0.001. Effects of ESW on Smad 
localization (B) and phosphorylation (C): Immunofluorescence for total-Smad (B) 
and phospho-Smad (C) was performed on cells either in basal conditions or in 
osteogenic medium after ESW treatment. Magnification 400x. I: DMEM; II: DMEM 
ESW; III: OST; IV: OST ESW. 
Figure 5. Signal transduction pathways involved in osteoblast differentiation by 
ESW treatment. Shock waves determine ROS production that induces ERK 
phosphorylation, as also reported by Wang et al. (2002b). This event leads to BMP2 
expression, followed by Smad 1/5/8 phosphorylation. Autocrine BMP2 signaling with 
consequent Smad phosphorylation may guide Runx2 expression (Phimphilai et al., 
2006; Liu et al., 2011). Finally, ERK can also phosphorylate Runx2 inducing its 
transcriptional activity (Kanno et al., 2007; Liu et al., 2011) that leads to ALP 
expression and activity.    
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Table 1 Primers for real-time PCR 
 
 
 
Runx2 
Sense: 5’- CGG AGT GGA CGA GGC AAG AG-3’ 
Antisense: 5’- AGG CGG TCA GAG AAC AAA CTA GG -3’ 
ALP
Sense: 5’- ATG AGG CGG TGG AGA TGG AC -3’ 
Antisense: 5’- CAT ACA GGA TGG CAG TGA AGG G -3’ 
BMP2 
Sense: 5’- CGG GAG AAG GAG GAG GCA AAG -3’ 
Antisense: 5’- GAA GCA GCA ACG CTA GAA GAC AG -3’ 
-ACT 
Sense: 5’- GCG AGA AGA TGA CCC AGA TC- 3’ 
Antisense: 5’- GGA TAG CAC AGC CTG GAT AG-3’ 
2-microglobulin 
Sense: 5’-AGA TGA GTA TGC CTG CCG TGT G-3’ 
Antisense: 5’-TCA ACC CTC CAT GAT GCT GCT TAC-3’ 
L1 
Sense: 5’-GCA AGC GGA TGA ACA CCA ACC-3’ 
Antisense: 5’-TTG AGG GCA GCA GGA ACC AC-3’ 
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Supplementary figure 1. Effect of osteogenic medium and ESW cell viability. At, 3, 
6 and 10 days after treatment, cell viability was determined by the WST-1 method, and 
expressed as ratio vs day 0 (DMEM). 
 
 
